A Novel Blood Proteomic Signature for Prostate Cancer

Prostate cancer is the most common malignant tumour in men. Improved testing for diagnosis, risk prediction, and response to treatment would improve care. Here, we identified a proteomic signature of prostate cancer in peripheral blood using data-independent acquisition mass spectrometry combined wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-02, Vol.15 (4), p.1051
Hauptverfasser:	Muazzam, Ammara, Spick, Matt, Cexus, Olivier N F, Geary, Bethany, Azhar, Fowz, Pandha, Hardev, Michael, Agnieszka, Reed, Rachel, Lennon, Sarah, Gethings, Lee A, Plumb, Robert S, Whetton, Anthony D, Geifman, Nophar, Townsend, Paul A
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids Age Antigens Apolipoproteins Biomarkers Biopsy Blood Cancer therapies Clotting Diagnosis Health aspects Life Sciences Mass spectrometry Mass spectroscopy Medical examination Medicare Older people Patients Peptides Peripheral blood Prostate cancer Prostate-specific antigen Proteins Proteomics Radiation therapy Scientific imaging Surveillance Tumors Urogenital system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!